At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Drug used in the examination of premature infants.drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy
In Brief
An observational study evaluating Drug used in the examination of premature infants. for Retinopathy of Prematurity. Completed, enrolled 60 participants.
Detailed Summary
Because of the neonatologists reported that some infants had suffered from vomiting, bradycardia, hypotonia, and aspiration risk about 30-60 minutes after the fundus examination in the intensive care unit. The investigators observed the pupil dilation effects and side effects of tipple instillation of phenylephrine 2.5% plus tropicamide 0.5% ophthalmic drop combination which the investigators routinely used in ROP examination.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRetinopathy of Prematurity
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
Primary CompletionOct 2017
Study CompletionDec 2017
First PostedFeb 2018
TodayJul 2026
First PostedFeb 28, 2018
Enrollment StartJan 15, 2016
Primary CompletionOct 15, 2017
Study CompletionDec 15, 2017
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.3 years ago
Interventions
Drug used in the examination of premature infants.drug
to investigate side effects of eye drops used